Knight Therapeutics Inc. (TSX: GUD) ('Knight'), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of JORNAY PM™ (methylphenidate HCI extended-release capsules) in ...

From ADHD to anxiety and everything in between, self-diagnosis is booming on social media. But as personality quirks become ...

A growing number of adults are discovering that what once felt like chaos or a character flaw was, in fact, undiagnosed ADHD.

Long-time advocate, Paris Hilton, shares her personal ADHD journey from childhood to adulthood to encourage others to speak to their ...

KEGE Center for ADHD, a trailblazing psychiatric clinic known for its lived-experience-led approach to ADHD care, has announced a major expansion across Arizona. This growth initiative includes ...

KEGE Center for ADHD, a psychiatric practice specializing in evidence-based ADHD evaluation and coordinated care, has announced a series of clinical enhancements designed to improve patient access, ...

In the randomized, double-blind, pediatric and adolescent, placebo-controlled study, CTx-1301 delivered rapid onset of effect ...

Adhd is one of the most common psychiatric diagnoses in adults that affects approximately 1 in 16 adults and 1 in 10 children ...

Globally, about 5 percent of children and 2.5 percent of adults have ADHD. For many, the way their brains work means they ...

NYU Langone offers an Innovations in Treatment Delivery of Empirically Supported Assessment & Treatment for Challenges in ...

Little T.J. was a monster. There's no other way to say it. Extremely hyperactive, the toddler ran around in circles, destroying everything in his path. He choked the cat and dragged it by its tail. He ...